[Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?]
- PMID: 26853278
- DOI: 10.1016/j.bulcan.2015.12.005
[Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?]
Abstract
Malignant epithelial tumors (carcinomas) are the most common ovarian cancers and the most lethal gynecological malignancies. Based on their heterogeneous morphology, a dualistic model of carcinogenesis was proposed in 2004. Type I carcinomas, composed of low grade serous, endometrioid, mucinous, clear cell carcinomas and malignant Brenner tumors, were distinct from type II carcinomas (high grade serous, undifferentiated carcinomas and carcinosarcomas). However, clinical studies failed to demonstrate the prognostic value of such a classification. The main reproach to this dualistic model was that it lumped together in type I tumors, heterogeneous lesions such as clear cell and mucinous carcinomas. Recent advances on molecular genetic alterations and precursor lesions favor the classification of ovarian carcinomas as five distinct diseases. The dualistic model of carcinogenesis in type I and II can finally be applied only to serous ovarian carcinomas (low grade and high grade).
Keywords: Carcinomas; Carcinomes; Classification; Heterogeneous; Histologie; Histology; Hétérogénéité; Ovaire; Ovary.
Copyright © 2016 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.
Similar articles
-
TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.Exp Mol Pathol. 2013 Oct;95(2):235-41. doi: 10.1016/j.yexmp.2013.08.004. Epub 2013 Aug 18. Exp Mol Pathol. 2013. PMID: 23965232
-
[Recent advances on ovarian epithelial cancer: definition, subtypes and pathologic features].Zhonghua Bing Li Xue Za Zhi. 2013 Sep;42(9):624-8. Zhonghua Bing Li Xue Za Zhi. 2013. PMID: 24314254 Chinese. No abstract available.
-
Histological classification of ovarian cancer.Med Electron Microsc. 2003 Mar;36(1):9-17. doi: 10.1007/s007950300002. Med Electron Microsc. 2003. PMID: 12658347 Review.
-
Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.Oncology (Williston Park). 2016 Feb;30(2):166-76. Oncology (Williston Park). 2016. PMID: 26892153 Review.
-
Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.Pathology. 2011 Aug;43(5):420-32. doi: 10.1097/PAT.0b013e328348a6e7. Pathology. 2011. PMID: 21716157 Review.
Cited by
-
Aberrant MAPK Signaling Offers Therapeutic Potential for Treatment of Ovarian Carcinoma.Onco Targets Ther. 2022 Nov 5;15:1331-1346. doi: 10.2147/OTT.S361512. eCollection 2022. Onco Targets Ther. 2022. PMID: 36388156 Free PMC article. Review.
-
Decoding the pathological and genomic profile of epithelial ovarian cancer.Sci Rep. 2024 Nov 19;14(1):28573. doi: 10.1038/s41598-024-80030-z. Sci Rep. 2024. PMID: 39562613 Free PMC article.
-
Novel Effects of Statins on Cancer via Autophagy.Pharmaceuticals (Basel). 2022 May 24;15(6):648. doi: 10.3390/ph15060648. Pharmaceuticals (Basel). 2022. PMID: 35745567 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical